Blood test could help doctors personalize lymphoma care
NCT ID NCT03758989
Summary
This study is testing if a simple blood test can help doctors better manage early-stage lymphoma. It aims to see if tracking tiny bits of tumor DNA in the blood can predict treatment success and help decide which patients need radiation. The goal is to personalize therapy to control the disease while potentially reducing side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DLBCL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Rochester
RECRUITINGRochester, New York, 14642, United States
Contact
Conditions
Explore the condition pages connected to this study.